Human challenge study to accelerate dengue vaccine development

Researchers recently conducted a controlled human challenge study that suggests an experimental dengue vaccine can give healthy volunteers full protection, urging experts to use this evidence to accelerate the development of a dengue vaccine. Read More »

Real-time system monitors Ebola through a microscope

Scientists recently published an article in mBio, a journal from the American Society for Microbiology, that suggests the first real-time system can monitor Ebola through a microscope while the Ebola-like virus particles infect and bond with human cells. Read More »

Study challenges strategy for developing vaccine for MERS-CoV

A recent Seoul National University College of Medicine study shows that the current strategy for developing a vaccine for the Middle East Respiratory Syndrome coronavirus (MERS-CoV) needs to be improved, as the virus mutates during an outbreak so that it becomes less virulent. Read More »

Obama administration releases details to broaden malaria initiative

President Barack Obama has already made significant changes to the anti-malaria efforts, which started 10 years ago with George W. Bush's President’s Malaria Initiative (PMI). Read More »

Japan donates funds for vaccinations in Ebola-stricken areas

Japan recently agreed to send $18.5 million to Gavi to finance vaccination services in countries that are suffering from Ebola, the virus that recently caused a West African outbreak. Read More »

Study shows flu vaccine's effectiveness varies for pregnant women

Scientists recently conducted a study that demonstrates that pregnant women have different T-follicular helper (Thf) cell expansion according to their trimester, which affects the effectiveness of the influenza vaccine. Read More »

$65.1 million initiative to boost malaria fight in Africa

UNITAID and the Innovative Vector Control Consortium (IVCC) recently developed a new $65.1 million initiative that is designed to improve malaria control while fighting insecticide resistance. Read More »

US grants $21 million to India’s fight against TB

The U.S. Agency for International Development recently granted three new awards to India as its government strives to eliminate tuberculosis (TB) from the nation. Read More »

US Agency for International Development initiates National Action Plan against drug-resistant TB

The U.S. Agency for International Development (USAID) recently initiated the White House's National Action Plan for Combatting Multidrug-Resistant Tuberculosis (MDR-TB). Read More »

Gavi teams with Merck to purchase Ebola vaccine

Gavi, the Vaccine Alliance, and Merck Sharp & Dohme Corp. (MSD) have committed to supporting the purchase of an Ebola vaccine to protect people from outbreaks of the deadly disease. Read More »

USAID issues call for HIV/AIDS vaccine grant proposals

USAID has issued a call for grant proposals as of Dec. 11 for those interested in furthering research on vaccines for treatment of HIV/AIDS. The grant must focus upon vaccine engineering and development for treating HIV/AIDS, and may specialize in particular upon women infected with HIV/AIDS. The target population for the grant and research is not limited to the U.S. Read More »

Two new studies explore containment options for camel-transmitted MERS

While camels are useful and beloved creatures, they also harbor the ability to transmit to humans communicable forms of MERS coronavirus. Read More »

Australian researchers develop fast, inexpensive TB test

Researchers at the University of Queensland's Australian Institute for Bioengineering and Nanotechnology have come up with a quick and inexpensive way to accurately detect tuberculosis (TB) in developing countries. Read More »

Gavi CEO calls for coordinated vaccine approach to control measles outbreaks

Despite a welcome reduction in measles deaths worldwide, the highly infectious disease “continues to take a terrible toll on the lives of children around the world,” Seth Berkley, CEO of Gavi, the Vaccine Alliance, told Vaccine News Daily recently. Read More »

New measles vaccine could save millions

A recent study demonstrates an innovative measles and rubella vaccine, which has received approval from the Board of Gavi (the Vaccine Alliance), is effective enough to help save over a million people. Read More »

Pediatric group seeks better access to HIV/AIDS treatment for children

Leaders with the Global Pediatric Antiretroviral Commitment-to-Action recently introduced awards of public recognition that emphasize the need for improving accessibility to HIV/AIDS treatments for children. Read More »

USAID renews commitment to helping vulnerable children

On Nov. 20, which is Universal Children’s Day, the U.S. Agency for International Development (USAID) recommitted to helping protect the world’s most vulnerable children   Read More »

US continues to support TB prevention in India

Officials from India and the United States, which has funded approximately $100 million in prevention and control measures against tuberculosis (TB) in the Asian nation, recently noted more than 15 million people have received vaccines over the last 18 years. Read More »

Brain scan shows cognitive deficits in HIV patients

Neuroscientists from the Georgetown University Medical Center recently conducted a study that uses brain scans to show the cognitive deficits found in older adults who have HIV infections. Read More »

New vaccine to protect Somali children from polio

Somalia has introduced a vaccine to protect children and maintain the nation's polio-free status. Read More »